Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

'Transforming screening, diagnosis and treatment of prostate cancer'


Professor Hashim U. AhmedHashim is currently Chair of Urology and Head of the Section of Specialty Surgery at Imperial College London which incorporates breast, ENT, head and neck, neurosurgery, ophthalmology, urology and vascular surgery. He heads up the Imperial Prostate group since 2017 when he took up the Chair of Urology having previously been at UCL as a MRC Clinical Research Training Fellow for his PhD, followed by an MRC Clinician Scientist Fellowship which incorporated his position as Clinical Senior Lecturer and then Reader in Urology. He currently holds a Wellcome Senior Research Fellowship (2017 to 2027). His research interests are in health technology assessment with a strong focus on clinical trials that bring innovative and transformative changes to the prostate cancer pathway from screening through to treatment of advanced disease. This has been and is supported by a grant income over the last 10 years of approximately £30M as lead applicant and £12M as co-applicant. He has well over 400 peer reviewed publications. He is active clinically, dealing with benign and malignant diseases of the prostate within the outpatient setting and operatively with minimally invasive approaches. As a result, he has and continues to train and support numerous urologists internationally in the specialised techniques that he has pioneered.


All members of the University and NHS clinical staff are welcome.

Please email Louise King if you would like to attend online.